LYME DISEASE BIOBANK FOUNDATION
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$745,615
Other
94%
Program Services
6%
Contributions
0%
Government Grants
0%
Fundraising Events
0%
Membership Dues
0%
Investments
0%
Expenses in 2024
$778,918
Other
75%
Salaries & Benefits
21%
Fees to Service Providers
3%
Offices, Occupancy & IT
<1%
Grants
0%
Benefits to Members
0%
Advertising & Promotion
0%
Interest
0%
Depreciation
0%
Revenues
2023
2024
Change
Contributions
$124
$0
-100%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$15,498
$44,822
+189%
Membership Dues
$0
$0
-
Investments
$0
$0
-
Other
$813,495
$700,793
-14%
Total Revenues
$829,117
$745,615
-10%
Expenses
2023
2024
Change
Grants
$0
$0
-
Benefits to Members
$0
$0
-
Salaries & Benefits
$164,135
$165,495
+1%
Fees to Service Providers
$1,723
$26,483
+1437%
Advertising & Promotion
$3,400
$0
-100%
Offices, Occupancy & IT
$0
$890
-
Interest
$0
$0
-
Depreciation
$0
$0
-
Other
$559,964
$586,050
+5%
Total Expenses
$729,222
$778,918
+7%
Net income
2023
2024
Change
Net income
+$99,895
-$33,303
-133%
Functional Expenses
Summary
2023
2024
Change
Program
$714,865
$766,916
+7%
Admin
$14,357
$11,907
-17%
Fundraising
$0
$95
-
Total Expenses
$729,222
$778,918
+7%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)